185 related articles for article (PubMed ID: 27384912)
1. Sulfur mustard inhalation: mechanisms of injury, alteration of coagulation, and fibrinolytic therapy.
White CW; Rancourt RC; Veress LA
Ann N Y Acad Sci; 2016 Aug; 1378(1):87-95. PubMed ID: 27384912
[TBL] [Abstract][Full Text] [Related]
2. Antifibrinolytic mechanisms in acute airway injury after sulfur mustard analog inhalation.
Rancourt RC; Ahmad A; Veress LA; Rioux JS; Garlick RB; White CW
Am J Respir Cell Mol Biol; 2014 Oct; 51(4):559-67. PubMed ID: 24796565
[TBL] [Abstract][Full Text] [Related]
3. Airway tissue plasminogen activator prevents acute mortality due to lethal sulfur mustard inhalation.
Veress LA; Anderson DR; Hendry-Hofer TB; Houin PR; Rioux JS; Garlick RB; Loader JE; Paradiso DC; Smith RW; Rancourt RC; Holmes WW; White CW
Toxicol Sci; 2015 Jan; 143(1):178-84. PubMed ID: 25331496
[TBL] [Abstract][Full Text] [Related]
4. Tissue factor pathway inhibitor prevents airway obstruction, respiratory failure and death due to sulfur mustard analog inhalation.
Rancourt RC; Veress LA; Ahmad A; Hendry-Hofer TB; Rioux JS; Garlick RB; White CW
Toxicol Appl Pharmacol; 2013 Oct; 272(1):86-95. PubMed ID: 23727623
[TBL] [Abstract][Full Text] [Related]
5. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Idell S
Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
[TBL] [Abstract][Full Text] [Related]
6. Editor's Highlight: Pulmonary Vascular Thrombosis in Rats Exposed to Inhaled Sulfur Mustard.
McGraw MD; Osborne CM; Mastej EJ; Di Paola JA; Anderson DR; Holmes WW; Paradiso DC; Garlick RB; Hendry-Hofer TB; Rancourt RC; Smith RW; Burns C; Roe GB; Rioux JS; White CW; Veress LA
Toxicol Sci; 2017 Oct; 159(2):461-469. PubMed ID: 28962529
[TBL] [Abstract][Full Text] [Related]
7. Bronchiolitis Obliterans and Pulmonary Fibrosis after Sulfur Mustard Inhalation in Rats.
McGraw MD; Dysart MM; Hendry-Hofer TB; Houin PR; Rioux JS; Garlick RB; Loader JE; Smith R; Paradiso DC; Holmes WW; Anderson DR; White CW; Veress LA
Am J Respir Cell Mol Biol; 2018 Jun; 58(6):696-705. PubMed ID: 29314868
[TBL] [Abstract][Full Text] [Related]
8. From the Cover: ImpairedProliferation and Differentiation of the Conducting Airway Epithelium Associated With Bronchiolitis Obliterans After Sulfur Mustard Inhalation Injury in Rats.
McGraw MD; Rioux JS; Garlick RB; Rancourt RC; White CW; Veress LA
Toxicol Sci; 2017 Jun; 157(2):399-409. PubMed ID: 28402575
[TBL] [Abstract][Full Text] [Related]
9. Exposure-response effects of inhaled sulfur mustard in a large porcine model: a 6-h study.
Fairhall SJ; Jugg BJ; Read RW; Stubbs SJ; Rutter SJ; Smith AJ; Mann TM; Jenner J; Sciuto AM
Inhal Toxicol; 2010 Dec; 22(14):1135-43. PubMed ID: 21083508
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary injury and oxidative stress in rats induced by inhaled sulfur mustard is ameliorated by anti-tumor necrosis factor-α antibody.
Malaviya R; Bellomo A; Abramova E; Croutch CR; Roseman J; Tuttle R; Peters E; Casillas RP; Sunil VR; Laskin JD; Laskin DL
Toxicol Appl Pharmacol; 2021 Oct; 428():115677. PubMed ID: 34390737
[TBL] [Abstract][Full Text] [Related]
11. Airway tissue factor-dependent coagulation activity in response to sulfur mustard analog 2-chloroethyl ethyl sulfide.
Rancourt RC; Veress LA; Guo X; Jones TN; Hendry-Hofer TB; White CW
Am J Physiol Lung Cell Mol Physiol; 2012 Jan; 302(1):L82-92. PubMed ID: 21964405
[TBL] [Abstract][Full Text] [Related]
12. Airway obstruction due to bronchial vascular injury after sulfur mustard analog inhalation.
Veress LA; O'Neill HC; Hendry-Hofer TB; Loader JE; Rancourt RC; White CW
Am J Respir Crit Care Med; 2010 Dec; 182(11):1352-61. PubMed ID: 20639443
[TBL] [Abstract][Full Text] [Related]
13. Pathological studies on the protective effect of a macrolide antibiotic, roxithromycin, against sulfur mustard inhalation toxicity in a rat model.
Gao X; Anderson DR; Brown AW; Lin H; Amnuaysirikul J; Chua AL; Holmes WW; Ray P
Toxicol Pathol; 2011 Dec; 39(7):1056-64. PubMed ID: 21934141
[TBL] [Abstract][Full Text] [Related]
14. Inhaled unfractionated heparin improves abnormalities of alveolar coagulation, fibrinolysis and inflammation in endotoxemia-induced lung injury rats.
Wang ZY; Wu SN; Zhu ZZ; Yang BX; Zhu X
Chin Med J (Engl); 2013 Jan; 126(2):318-24. PubMed ID: 23324284
[TBL] [Abstract][Full Text] [Related]
15. Tissue plasminogen activator prevents mortality from sulfur mustard analog-induced airway obstruction.
Veress LA; Hendry-Hofer TB; Loader JE; Rioux JS; Garlick RB; White CW
Am J Respir Cell Mol Biol; 2013 Apr; 48(4):439-47. PubMed ID: 23258228
[TBL] [Abstract][Full Text] [Related]
16. Intratracheal heparin improves plastic bronchitis due to sulfur mustard analog.
Houin PR; Veress LA; Rancourt RC; Hendry-Hofer TB; Loader JE; Rioux JS; Garlick RB; White CW
Pediatr Pulmonol; 2015 Feb; 50(2):118-26. PubMed ID: 24692161
[TBL] [Abstract][Full Text] [Related]
17. Current view on alveolar coagulation and fibrinolysis in acute inflammatory and chronic interstitial lung diseases.
Wygrecka M; Jablonska E; Guenther A; Preissner KT; Markart P
Thromb Haemost; 2008 Mar; 99(3):494-501. PubMed ID: 18327397
[TBL] [Abstract][Full Text] [Related]
18. Mechanism underlying acute lung injury due to sulfur mustard exposure in rats.
Xiaoji Z; Xiao M; Rui X; Haibo C; Chao Z; Chengjin L; Tao W; Wenjun G; Shengming Z
Toxicol Ind Health; 2016 Aug; 32(8):1345-1357. PubMed ID: 25537624
[TBL] [Abstract][Full Text] [Related]
19. Inhalation exposure systems for the development of rodent models of sulfur mustard-induced pulmonary injury.
Weber WM; Kracko DA; Lehman MR; Irvin CM; Blair LF; White RK; Benson JM; Grotendorst GR; Cheng YS; McDonald JD
Toxicol Mech Methods; 2010 Jan; 20(1):14-24. PubMed ID: 20025432
[TBL] [Abstract][Full Text] [Related]
20. Emerging targets for treating sulfur mustard-induced injuries.
Ahmad S; Ahmad A
Ann N Y Acad Sci; 2016 Jun; 1374(1):123-31. PubMed ID: 27285828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
